Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2008
12/04/2008WO2008145842A2 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof
12/04/2008WO2008145759A1 New silver(i) compounds and their use in pharmaceutical compositions for the treatment, prophylaxis and prevention of infections
12/04/2008WO2008145562A1 Non-nucleoside reverse transcriptase inhibitors
12/04/2008WO2008145021A1 A truncated l1 protein of human papillomavirus 6
12/04/2008WO2008145020A1 A truncated l1 protein of human papillomavirus 11
12/04/2008WO2008145000A1 A foot-and-mouth disease virus double-effective vaccine vector, construction method and uses thereof
12/04/2008WO2008144996A1 Stable pharmaceutical cucurbitacin liquid composition
12/04/2008WO2008144924A1 Immunogenic compositions comprising an agent capable of modulating a cd 1d-modulated pathway and methods of use
12/04/2008WO2008144888A1 Formulations for the oral administration of therapeutic agents and related methods
12/04/2008WO2008126024A3 Oxazolidinone antibiotic derivatives
12/04/2008WO2008116468A3 Mhc peptide complexes and uses thereof in infectious diseases
12/04/2008WO2008079933A3 Heteroaryl-heteroaryl compounds as cdk inhibitors for the treatment of cancer, inflammation and viral infections
12/04/2008US20080300424 7-substituted fused ring tetracycline compounds
12/04/2008US20080300398 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents; HIV
12/04/2008US20080300384 T-bet compositions and methods of use thereof
12/04/2008US20080300317 Diamondoid derivatives possessing therapeutic activity in the treatment of viral disorders
12/04/2008US20080300288 Alkenyldiarylmethanes, Fused Analogs And Syntheses Thereof
12/04/2008US20080300287 Peptidic Compounds
12/04/2008US20080300271 Novel compounds and a novel process for their preparation
12/04/2008US20080300265 Antiviral drugs for treatment of arenavrus infection
12/04/2008US20080300258 Anhydrous ciprofloxacin hydrochloride
12/04/2008US20080300253 Treatment of inflammatory disorders with praziquantel
12/04/2008US20080300231 Antibacterial amide macrocycles VI
12/04/2008US20080300220 Linkable Lewis X Analogs
12/04/2008US20080300211 Microrna inhibition for the treatment of inflammation and myeloproliferative disorders
12/04/2008US20080300207 Protein production
12/04/2008US20080300201 Cell Cycle Arrest and Apoptosis
12/04/2008US20080300200 Therapeutic Furopyrimidines and Thienopyrimidines
12/04/2008US20080300199 Antibacterial 1,4,5-substituted aminoglycoside analogs
12/04/2008US20080300169 Development of Novel Antibiotic Alternatives
12/04/2008US20080299227 Method for removal of HIV from the gastrointestinal tract and bile of HIV-infected subjects and for the prevention of drug failure and prevention of development of AIDS in HIV-infected subjects
12/04/2008US20080299198 Polystyrene sulfonate polymer tablets, their preparation and use
12/04/2008US20080299184 diagnosing nonsmall cell lung cancer by analyzing PCDH20 gene in a lung sample; measurement of the expression level of the cancer-suppressing gene and methylation of genomic DNA
12/04/2008US20080299180 Peptides based on the sequence of human lactoferrin and their use
12/04/2008US20080299165 Compositions for Treatment of Diseases of the Nail Unit
12/04/2008US20080299160 Method of Manufacture of Polymer Composites
12/04/2008US20080299153 B. anthracis prevention and treatment: mutant b. anthracis lacking luxs activity and furanone inhibition of growth, ai-2 quorum sensing, and toxin production
12/04/2008US20080299152 Norovirus Vaccine Formulations
12/04/2008US20080299151 Influenza vaccines
12/04/2008US20080299150 Method and system for processing immuno-competent cells in view of an antiviral therapy, and related therapeutic process
12/04/2008US20080299142 Compounds and methods for treatment and diagnosis of chlamydial infection
12/04/2008US20080299140 Immunogenic Composition and Peptide Sequences for Prevention and Treatment of an Hsv Condition
12/04/2008US20080299132 Synergistic compositions for treating HIV-1
12/04/2008US20080299131 Anti-Viral Compositions
12/04/2008US20080299124 Novel method for the stabilization of chimeric immunoglobulin or immunoglobulin fragments and, and stabilized anti-egp-2 scfv fragment
12/04/2008US20080299121 Multivalent recombinant antibodies for treating HRV infections
12/04/2008US20080299120 Multivalent antibodies and uses therefor
12/04/2008US20080299119 Polypeptides homologous to vegf and bmp1
12/04/2008US20080299114 Humaneered anti-factor b antibody
12/04/2008US20080299112 Human Polyclonal Antibodies from Genetically Engineered Animals
12/04/2008US20080299105 Inhibition of Feline Calicivirus
12/04/2008US20080299101 Cancer Treatment Resistance and Agents Modulating Such Resistance
12/04/2008US20080299098 Broad-Spectrum Antibacterial and Antifungal Activity of Lactobacillus Johnsonii D115
12/04/2008US20080299095 Nup98-Hox Fusions for Expansion of Hemopoietic Stem Cells
12/04/2008US20080299085 Using fusion protein comprised of terminal reporter molecules to rapidly detect virus binding and entry into cells; receptor-dependent targeted therapy; viricides
12/04/2008US20080299083 Adenoviral vectors having a protein IX deletion
12/04/2008US20080299082 Novel recombinant T4 phage particle containing HIV, H. pylori or cancer antigens and uses thereof
12/04/2008US20080299081 Polynucleotides and Polypeptides of the IFNalpha-21 Gene
12/04/2008US20080299080 Thiophene analogues for the treatment or prevention of flavivirus infections
12/04/2008US20080299075 a mixture of viricides such as dimethyl(4,4'-biphenyldiylbis(1H-imidazole-4,2-diyl((1S)-2-methyl-1,1-propanediyl)imino((2S)-1-oxo-1,2-propanediyl)))biscarbamate, carriers and one or two additional antiviral drugs, used for the treatment of viral infections
12/04/2008US20080299072 Chemokine Antagonists
12/04/2008US20080299071 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
12/04/2008US20080299070 Antiviral Compounds
12/04/2008US20080299042 Membrane Associated Molecules
12/04/2008CA2688346A1 Compositions and methods for enhancing immune responses to vaccines
12/04/2008CA2688194A1 Antiviral drugs for treatment or prevention of dengue infection
12/04/2008CA2688036A1 Formulations for the oral administration of therapeutic agents and related methods
12/04/2008CA2687817A1 Heteroaryl substituted thiazoles
12/04/2008CA2687790A1 Antifungal agents
12/04/2008CA2687747A1 Non-nucleoside reverse transcriptase inhibitors
12/03/2008EP1997823A1 Boronic ester and acid compounds, synthesis and uses
12/03/2008EP1997804A1 Mmp-13-selective inhibitor
12/03/2008EP1996715A1 Bacterial antigens and uses thereof
12/03/2008EP1996615A2 Broad spectrum antiviral compositions
12/03/2008EP1996593A2 Pharmaceutically acceptable salts and polymorphic forms
12/03/2008EP1996579A2 Antibiotic compounds
12/03/2008EP1996565A2 Substituted aminothiazole derivatives with anti-hcv activity
12/03/2008EP1996553A2 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
12/03/2008EP1996209A1 Contraceptive composition
12/03/2008EP1996202A1 Chemical compounds
12/03/2008EP1996180A1 Antibacterial agents
12/03/2008EP1831230B1 Process for obtaining levofloxacin free from salts
12/03/2008EP1560573B1 Use of n,n-dicylcohexyl-2-hydroxy-7,7-dimethylbicyclo[2.2.1]hept-1-ylmethanesulfonamide family members in therapy
12/03/2008EP1538980A4 Devices and methodologies useful in body aesthetics
12/03/2008EP1511499B1 Immunomodulatory compounds and methods of use thereof
12/03/2008EP1492785B1 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
12/03/2008EP1470144B1 Oligonucleotides comprising alternating segments and uses thereof
12/03/2008EP1377540B1 Inhibitors of integrin alpha-v-beta-6
12/03/2008EP1294858B1 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
12/03/2008EP1204677B1 Cyclohexapeptide compounds, process for their production and their use as a pharmaceutical
12/03/2008EP1175217B1 (s)-benzoquinolizine carboxylic acids and their use as antibacterial agents
12/03/2008EP1028961B3 Pleuromutilin derivatives as antimicrobials
12/03/2008EP0812208B1 Pharmaceutical compositions for controlled release of soluble receptors
12/03/2008EP0606217B2 Ctl4a receptor, fusion proteins containing it and uses thereof
12/03/2008CN101316859A Aryiialkyl and heteroarylalkyl derivatives of cyclosporine A for the treatment and prevention of viral infection
12/03/2008CN101316850A Substituted aminophenylsulfonamide compounds as HIV protease inhibitor
12/03/2008CN101316834A 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent PARP inhibitors
12/03/2008CN101316606A Methods and pharmaceutical compositions for the treatment and prevention of hepatitis c infection
12/03/2008CN101314775A RNA disturbance target point capable of being used for treating AIDS
12/03/2008CN101314763A Short bifidobacteria with functions of anti-gastrointestinal tract pathogen, oxidation resistance and blood pressure reduction
1 ... 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 ... 1798